University of Mississippi Medical Center

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Mississippi Medical Center sits in the top decile of US sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count).

96 total trials 10 currently recruiting 65 completed top decile by trial count

University of Mississippi Medical Center: 96 sponsored US clinical trials, 10 recruiting.

University of Mississippi Medical Center sponsors 96 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 65 completed. 10 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sedentary Behavior, with 2 trials.

Top-decile sponsor footprint

University of Mississippi Medical Center ranks in the top decile of sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 45/100

65 of 79 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

96 total, page 2 of 2

TERMINATED NA

Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis

NCT01921348
COMPLETED NA

Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals

NCT01784692
COMPLETED

Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection.

NCT03237195
COMPLETED Phase 2

Rapid Administration of Carnitine in sEpsis

NCT01665092
COMPLETED NA

Optimal Timing of Cord Clamping in Preterm Pregnancy Following Vaginal or Cesarean Delivery

NCT01766908
COMPLETED Phase 4

A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites

NCT01722994
COMPLETED NA

Effects of Health Promoting Programs on Cardiovascular Disease Risk

NCT02019953
TERMINATED NA

Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES):

NCT02027272
COMPLETED NA

Impact of Blueberries on Uric Acid and Quality of Life

NCT01532622
COMPLETED NA

Effects of Aerobic Exercise Within a Behavioral Treatment Program for Chronic Headaches

NCT01525303
COMPLETED Phase 2

Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress

NCT01267227
COMPLETED NA

Effect of Mirror Therapy on Lower Extremity Motor Control and Gait in Patients With Stroke

NCT01574079
COMPLETED

PD2i Analysis of Heart Rate Variability in Competitive Sports

NCT01249248
TERMINATED

Bone to Skin Thickness Study: Obese Versus Normal Population

NCT01248182
COMPLETED

Evaluating Factors That Impact Loss to Follow-up Among Postpartum HIV-infected Women in Mississippi

NCT01190605
COMPLETED

Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees

NCT01162668
COMPLETED NA

Stress Intervention for Chronic Urticaria

NCT01111136
TERMINATED NA

The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study

NCT01701622
COMPLETED

Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy

NCT01248169
COMPLETED

Trichomoniasis: Genotype and Phenotype Correlations in African American Women

NCT00998530
TERMINATED

Study of the Impact of a Pain Diary in Pediatric Patients

NCT00935207
COMPLETED NA

Interpregnancy Care Project-Mississippi (IPC-M)

NCT00852319
COMPLETED

Sexually Transmitted Infections Among African American Women Who Have Sex With Women

NCT01043081
TERMINATED NA

A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives

NCT00825188
TERMINATED NA

Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate

NCT00849810
COMPLETED NA

Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence - Posttraumatic Stress Disorder

NCT01409707
COMPLETED

Optic Discs in Children With Cerebral Palsy

NCT00769197
COMPLETED NA

Effects of Hoodia on Blood Pressure and Heart Function

NCT00693264
COMPLETED

Clarksdale Diabetes and Metabolism Clinic CHEC Study

NCT00791453
COMPLETED Phase 2

Impact of Mulberry Leaf on Type 2 Diabetes

NCT00795704
COMPLETED

Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias

NCT00654251
COMPLETED

Sedentary Behavior in Overweight Women

NCT00613353
COMPLETED

Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)

NCT00653809
COMPLETED

Advanced Grandparental Age as a Risk Factor for Autism

NCT00464477
COMPLETED

Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome

NCT00433355
COMPLETED Phase 4

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

NCT00691873
COMPLETED Phase 4

Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

NCT00329381
COMPLETED Phase 3

Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis

NCT00432835
COMPLETED NA

Pedicle Screw Usage in Conventional Fixation Pattern Constructs Compared to Thoracic Hook Constructs in Scoliosis

NCT01581021
COMPLETED NA

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

NCT00227058
TERMINATED NA

Soluble CD23 Expression in Asthma Patients Treated With OMA

NCT00226200
TERMINATED Phase 4

Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?

NCT00334204
COMPLETED NA

Tocolysis for Preterm Labor

NCT00811057
COMPLETED NA

The Use of Progesterone to Reduce Preterm Birth

NCT00830765
COMPLETED

Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia

NCT00583635
COMPLETED NA

Mild Preeclampsia Near Term: Deliver or Deliberate?

NCT00789919
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 5
Phase 3 5
Phase 4 5

Therapeutic Areas

Sedentary Behavior 2
Preeclampsia 2
Spinal Cord Injuries 2
Obesity 2
Pregnancy; Hypertension, Gestational Hypertension, With Albuminuria (Severe Pre-eclampsia) 1
Delivery; Proteinuria, With Gestational Hypertension (Pre-eclampsia, Severe) 1
Pregnancy; Proteinuria, With Hypertension (Severe Pre-eclampsia) 1
Preoperative Sedation 1
Antioxidant 1
Sickle Cell Anemia in Children 1

What is open in the University of Mississippi Medical Center pipeline

10 recruiting of 96 indexed (10% open); 65 completed (68%).

Phase mix: 10 late (III/IV) vs 10 early (I/II) (balanced across stages).

Top condition: Sedentary Behavior (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Mississippi Medical Center: open-pipeline peers nationwide

Peers matched on 96 registered trials and 10% open enrollment, not the therapeutic-area sidebar.

University of Mississippi Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 0%5%10%15%20% Total trials Recruiting share University of Mississippi Medical CenterMasimo CorporationUniversity of TennesseeArkansas Children's Hospital Research InstituteAdventHealthZimmer BiometSWOG Cancer Research NetworkVertex Pharmaceuticals IncorporatedCalifornia Pacific Medical Center Research Institute
University of Mississippi Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Mississippi Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 96 trials (± recruiting share)

Sponsors near 10% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Mississippi Medical Center page

96 registered trials is a research-attention snapshot, not an endorsement of University of Mississippi Medical Center or any single study.

  • 10 of University of Mississippi Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Sedentary Behavior is the condition University of Mississippi Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sedentary Behavior trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Mississippi Medical Center pipeline card: 96 registered trials from official public datasets.Report a data error.